Key Metrics
CiteScore 

5
SJR 

Q2Biotechnology

SNIP 

0.94
Recommended pre-submission checks
Powered by 

Topics Covered on Future Science OA
Future Science OA Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | FUTURE SCI LTD |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | GBP 950 |
| Publication Time | 13 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Future Science OA ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Future Science OA
Evaluation of the impact of virtual reality as a non-pharmacological intervention for pain and anxiety during hematology procedures and chemotherapy: a controlled trial.
- 16 Oct 2026
- Future science OA
Statement of Retraction: Fischer's oligopeptide ratio in ischemic hypoxia: prophylactic amendment of sophoretin and melatonin supplementation.
- 16 Oct 2026
- Future science OA
TOMM5 is associated with oral cancer progression: a multi-omics analysis from single-cell atlas to in vitro validation
- 13 Oct 2026
- Future Science OA
Functional thiamine deficiency in patients with chronic kidney disease in Northeast Thailand
- 9 Oct 2026
- Future Science OA
Index-window C-reactive protein and carcinoembryonic antigen and five-year all-cause mortality in Hispanic/Latino and non-Hispanic White patients with colorectal cancer: a retrospective biomarker cohort study
- 8 Oct 2026
- Future Science OA
Dapagliflozin for attenuating early anthracycline-associated cardiac changes (DAPA-AIC): a randomized, double-blind, placebo-controlled trial
- 6 Oct 2026
- Future Science OA
Evaluation of the impact of virtual reality as a non-pharmacological intervention for pain and anxiety during hematology procedures and chemotherapy: a controlled trial.
- 16 Oct 2026
- Future science OA
Statement of Retraction: Fischer's oligopeptide ratio in ischemic hypoxia: prophylactic amendment of sophoretin and melatonin supplementation.
- 16 Oct 2026
- Future science OA
TOMM5 is associated with oral cancer progression: a multi-omics analysis from single-cell atlas to in vitro validation
- 13 Oct 2026
- Future Science OA
Functional thiamine deficiency in patients with chronic kidney disease in Northeast Thailand
- 9 Oct 2026
- Future Science OA
Index-window C-reactive protein and carcinoembryonic antigen and five-year all-cause mortality in Hispanic/Latino and non-Hispanic White patients with colorectal cancer: a retrospective biomarker cohort study
- 8 Oct 2026
- Future Science OA
Dapagliflozin for attenuating early anthracycline-associated cardiac changes (DAPA-AIC): a randomized, double-blind, placebo-controlled trial
- 6 Oct 2026
- Future Science OA